Dan Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Dan Li has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
- Jin Wang
Stony Brook University
17 shared publications - Erkang Wang
State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry
10 shared publications Qing Dong
10 shared publicationsErkang Wang
9 shared publicationsBaoji Du
State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130022, China
5 shared publicationsFan Feng
5 shared publications
Latest Publications
- 14 July 2026
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 467
Signal-amplified ECL biosensor for exosomes: Integrating Zr-MOF/Au nanoclusters with catalytic hairpin assembly
- 14 July 2026
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 467
Signal-amplified ECL biosensor for exosomes: Integrating Zr-MOF/Au nanoclusters with catalytic hairpin assembly
- 3 October 2025
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 417 (27) , 6241-6253
A two-signal aptasensor for sensitive exosome detection via rolling circle amplification and G-quadruplex structure
Exosomes play a pivotal role in cancer diagnosis and therapy, yet their clinical application faces significant technical challenges. To address this, we developed a sensitive, aptamer-based platform that integrates nucleic acid amplification and a G-quadruplex (G4) with two-signal output for exosome detection. Our approach employs CD63 antibody-conjugated magnetic beads (MBs) for efficient exosome capture and purification. The captured exosomes are then bound by CD63-specific aptamers embedded in rolling circle amplification (RCA) products, forming a sandwich complex with the MBs. The RCA products also contain G4 repeats, enabling two-signal output through interaction with Fe(III)-protoporphyrin IX (Hemin) and N-methylporphyrin-dipropionic acid IX (NMM). The G4-Hemin complex catalyzes the oxidation of 3,3′,5,5′-tetramethylbenzidine (TMB), producing a colorimetric signal, while the G4-NMM enhances fluorescence emission. This detection system achieves high sensitivity, with detection ranges of 4.0 × 103 to 4.0 × 107 particles/mL (colorimetric) and 4.0 × 102 to 4.0 × 106 particles/mL (fluorescence), and low detection limits of 1.78 × 103 particles/mL (colorimetric) and 96 particles/mL (fluorescence). Demonstrating high performance in complex media (10% exosome-depleted fetal bovine serum, FBS), this biosensor achieves sensitivity comparable to current methods at a low cost ($5.19 per test). This combination of robustness, sensitivity, and affordability makes it a highly promising platform for clinical exosome-based diagnostics. Graphical Abstract A two-signal aptasensor was elegantly designed for sensitive exosome detection. Magnetic beads (MBs) modified with CD63 antibodies were employed for efficient exosome capture and purification. The CD63 aptamers and G4-quadruplexes (G4) in the rolling circle amplification (RCA) products formed a sophisticated sandwich structure with exosomes. By integrating with Hemin and NMM, the system generated proportional colorimetric and fluorescence signals, offering a reliable and precise method for exosome quantification.
- 3 October 2025
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 417 (27) , 6241-6253
A two-signal aptasensor for sensitive exosome detection via rolling circle amplification and G-quadruplex structure
Exosomes play a pivotal role in cancer diagnosis and therapy, yet their clinical application faces significant technical challenges. To address this, we developed a sensitive, aptamer-based platform that integrates nucleic acid amplification and a G-quadruplex (G4) with two-signal output for exosome detection. Our approach employs CD63 antibody-conjugated magnetic beads (MBs) for efficient exosome capture and purification. The captured exosomes are then bound by CD63-specific aptamers embedded in rolling circle amplification (RCA) products, forming a sandwich complex with the MBs. The RCA products also contain G4 repeats, enabling two-signal output through interaction with Fe(III)-protoporphyrin IX (Hemin) and N-methylporphyrin-dipropionic acid IX (NMM). The G4-Hemin complex catalyzes the oxidation of 3,3′,5,5′-tetramethylbenzidine (TMB), producing a colorimetric signal, while the G4-NMM enhances fluorescence emission. This detection system achieves high sensitivity, with detection ranges of 4.0 × 103 to 4.0 × 107 particles/mL (colorimetric) and 4.0 × 102 to 4.0 × 106 particles/mL (fluorescence), and low detection limits of 1.78 × 103 particles/mL (colorimetric) and 96 particles/mL (fluorescence). Demonstrating high performance in complex media (10% exosome-depleted fetal bovine serum, FBS), this biosensor achieves sensitivity comparable to current methods at a low cost ($5.19 per test). This combination of robustness, sensitivity, and affordability makes it a highly promising platform for clinical exosome-based diagnostics. Graphical Abstract A two-signal aptasensor was elegantly designed for sensitive exosome detection. Magnetic beads (MBs) modified with CD63 antibodies were employed for efficient exosome capture and purification. The CD63 aptamers and G4-quadruplexes (G4) in the rolling circle amplification (RCA) products formed a sophisticated sandwich structure with exosomes. By integrating with Hemin and NMM, the system generated proportional colorimetric and fluorescence signals, offering a reliable and precise method for exosome quantification.
- 4 September 2025
- Published by American Chemical Society (ACS) in ACS Nano
Engineering Aggregation-Induced Emission Photosensitizers through a Counterion-Modulation Strategy for Enhanced Photodynamic Immunotherapy
The intersystem crossing (ISC) process of photosensitizers (PSs) is crucial for the generation of reactive oxygen species (ROS) in photodynamic immunotherapy. Herein, a counterion-regulation strategy is applied to enhance ISC efficiency in aggregation-induced emission (AIE) PSs, optimizing type-I ROS production. Three PSs with the same cationic donor-π-acceptor (D-π-A) structure, N,N-diphenyl-4-(7-(pyridin-4-yl)benzo[c][1,2,5]thiadiazol-4-yl)aniline (TBP+), were synthesized with different counterions: iodide (I-), hexafluorophosphate (PF6-), and tetraphenylborate (PhB-). Among them, TBP-PhB exhibits an improved AIE performance and type-I ROS generation. Theoretical calculation revealed that the augmented ROS production stems from increased ISC efficacy, facilitated by additional transition channels with smaller energy gaps and larger spin-orbit coupling values. Meanwhile, TBP-PhB demonstrated good photodynamic therapy efficacy under hypoxic tumor conditions. Additionally, TBP-PhB activated immunogenic cell death, promoted dendritic cell maturation, and stimulated cytotoxic T cells, thereby enhancing immunotherapy. Tumor inhibition was observed in both primary and distant tumors treated with TBP-PhB under light irradiation. Collectively, this work presents an approach to improving type-I ROS in AIE PSs by optimizing the ISC process, highlighting the potential of counterion modulation for developing efficient AIE PSs for advanced photodynamic immunotherapy.
- 4 September 2025
- Published by American Chemical Society (ACS) in ACS Nano
Engineering Aggregation-Induced Emission Photosensitizers through a Counterion-Modulation Strategy for Enhanced Photodynamic Immunotherapy
The intersystem crossing (ISC) process of photosensitizers (PSs) is crucial for the generation of reactive oxygen species (ROS) in photodynamic immunotherapy. Herein, a counterion-regulation strategy is applied to enhance ISC efficiency in aggregation-induced emission (AIE) PSs, optimizing type-I ROS production. Three PSs with the same cationic donor-π-acceptor (D-π-A) structure, N,N-diphenyl-4-(7-(pyridin-4-yl)benzo[c][1,2,5]thiadiazol-4-yl)aniline (TBP+), were synthesized with different counterions: iodide (I-), hexafluorophosphate (PF6-), and tetraphenylborate (PhB-). Among them, TBP-PhB exhibits an improved AIE performance and type-I ROS generation. Theoretical calculation revealed that the augmented ROS production stems from increased ISC efficacy, facilitated by additional transition channels with smaller energy gaps and larger spin-orbit coupling values. Meanwhile, TBP-PhB demonstrated good photodynamic therapy efficacy under hypoxic tumor conditions. Additionally, TBP-PhB activated immunogenic cell death, promoted dendritic cell maturation, and stimulated cytotoxic T cells, thereby enhancing immunotherapy. Tumor inhibition was observed in both primary and distant tumors treated with TBP-PhB under light irradiation. Collectively, this work presents an approach to improving type-I ROS in AIE PSs by optimizing the ISC process, highlighting the potential of counterion modulation for developing efficient AIE PSs for advanced photodynamic immunotherapy.
- 28 March 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (13) , 7212-7220
Enabling Sensitive Quantification of Exosomes Combining Aptamer-Based Rolling Circle Amplification and Silver Nanoparticles
Exosomes carry various biological information and are abundant in body fluids, making them a promising noninvasive biomarker for disease diagnosis and prognosis. However, current detection methods have limitations in sensitivity, specificity, and cost effectiveness, hindering their clinical application. To address these challenges, we have developed a fast, accurate, and cost-effective method for detecting exosomes with high sensitivity and specificity, making it ideal for clinical applications. Clusters of differentiation 63 (CD63) aptamer with its complementary DNA (CD63 aptamer/cDNA) linked to streptavidin-coated magnetic beads (SA-MBs) are used as a capture probe. Exosomes with CD63 proteins can bind to the aptamer and release the cDNA, which initiates rolling circle amplification (RCA) to magnify the cDNA copies. The negatively charged RCA products induce the aggregation of positively charged spermine-modified silver nanoparticles (AgNPs) through electrostatic attraction. The aggregation of AgNPs can be observed visually with the naked eye or quantitatively analyzed using ultraviolet-visible (UV-vis) spectroscopy to determine the concentration of exosomes, with limits of detection of 4.0 × 104 particles/mL for visual observation and 800 particles/mL for UV-vis spectroscopy, respectively. The method has also been demonstrated for detecting the exosomes in serum samples, indicating its potential for clinical use in liquid biopsy.
- 28 March 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (13) , 7212-7220
Enabling Sensitive Quantification of Exosomes Combining Aptamer-Based Rolling Circle Amplification and Silver Nanoparticles
Exosomes carry various biological information and are abundant in body fluids, making them a promising noninvasive biomarker for disease diagnosis and prognosis. However, current detection methods have limitations in sensitivity, specificity, and cost effectiveness, hindering their clinical application. To address these challenges, we have developed a fast, accurate, and cost-effective method for detecting exosomes with high sensitivity and specificity, making it ideal for clinical applications. Clusters of differentiation 63 (CD63) aptamer with its complementary DNA (CD63 aptamer/cDNA) linked to streptavidin-coated magnetic beads (SA-MBs) are used as a capture probe. Exosomes with CD63 proteins can bind to the aptamer and release the cDNA, which initiates rolling circle amplification (RCA) to magnify the cDNA copies. The negatively charged RCA products induce the aggregation of positively charged spermine-modified silver nanoparticles (AgNPs) through electrostatic attraction. The aggregation of AgNPs can be observed visually with the naked eye or quantitatively analyzed using ultraviolet-visible (UV-vis) spectroscopy to determine the concentration of exosomes, with limits of detection of 4.0 × 104 particles/mL for visual observation and 800 particles/mL for UV-vis spectroscopy, respectively. The method has also been demonstrated for detecting the exosomes in serum samples, indicating its potential for clinical use in liquid biopsy.
- 29 September 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (8) , e2402785
Advancements in NADH Oxidase Nanozymes: Bridging Nanotechnology and Biomedical Applications
Nicotinamide adenine dinucleotide (NADH) oxidase (NOX) is key in converting NADH to NAD + , crucial for various biochemical pathways. However, natural NOXs are costly and unstable. NOX nanozymes offer a promising alternative with potential applications in bio‐sensing, antibacterial treatments, anti‐aging, and anticancer therapies. This review provides a comprehensive overview of the types, functional mechanisms, biomedical applications, and future research perspectives of NOX nanozymes. It also addresses the primary challenges and future directions in the research and development of NOX nanozymes, underscoring the critical need for continued investigation in this promising area. These challenges include optimizing the catalytic efficiency, ensuring biocompatibility, and achieving targeted delivery and controlled activity within biological systems. Additionally, the exploration of novel materials and hybrid structures holds great potential for enhancing the functional capabilities of NOX nanozymes. Future research directions can involve integrating advanced computational modeling with experimental techniques to better understand the underlying mechanisms and to design more effective nanozyme candidates. Collaborative efforts across disciplines such as nanotechnology, biochemistry, and medicine will be essential to unlock the full potential of NOX nanozymes in future biomedical applications.
- 29 September 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (8) , e2402785
Advancements in NADH Oxidase Nanozymes: Bridging Nanotechnology and Biomedical Applications
Nicotinamide adenine dinucleotide (NADH) oxidase (NOX) is key in converting NADH to NAD + , crucial for various biochemical pathways. However, natural NOXs are costly and unstable. NOX nanozymes offer a promising alternative with potential applications in bio‐sensing, antibacterial treatments, anti‐aging, and anticancer therapies. This review provides a comprehensive overview of the types, functional mechanisms, biomedical applications, and future research perspectives of NOX nanozymes. It also addresses the primary challenges and future directions in the research and development of NOX nanozymes, underscoring the critical need for continued investigation in this promising area. These challenges include optimizing the catalytic efficiency, ensuring biocompatibility, and achieving targeted delivery and controlled activity within biological systems. Additionally, the exploration of novel materials and hybrid structures holds great potential for enhancing the functional capabilities of NOX nanozymes. Future research directions can involve integrating advanced computational modeling with experimental techniques to better understand the underlying mechanisms and to design more effective nanozyme candidates. Collaborative efforts across disciplines such as nanotechnology, biochemistry, and medicine will be essential to unlock the full potential of NOX nanozymes in future biomedical applications.
- Open Access
- 31 March 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 710, 149863
The role of macrophage polarization in vascular calcification
- 31 March 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 710, 149863
Open AccessThe role of macrophage polarization in vascular calcification
- 10 September 2023
- Published by Wiley in Advanced Healthcare Materials
- Vol. 12 (28) , e2301413
Mn2+/Ir3+‐Doped and CaCO3‐Covered Prussian Blue Nanoparticles with Indocyanine Green Encapsulation for Tumor Microenvironment Modulation and Image‐Guided Synergistic Cancer Therapy
The development of smart theranostic nanoplatforms has gained great interest in effective cancer treatment against the complex tumor microenvironment (TME), including weak acidity, hypoxia, and glutathione (GSH) overexpression. Herein, a TME‐responsive nanoplatform named PMICApt/ICG, based on PB:Mn&Ir@CaCO3Aptamer/ICG, is designed for the competent synergistic photothermal therapy and photodynamic therapy (PDT) under the guidance of photothermal and magnetic resonance imaging. The nanoplatform's aptamer modification targeting the transferrin receptor and the epithelial cell adhesion molecule on breast cancer cells, and the acid degradable CaCO3 shell allow for effective tumor accumulation and TME‐responsive payload release in situ. The nanoplatform also exhibits excellent PDT properties due to its ability to generate O2 and consume antioxidant GSH in tumors. Additionally, the synergistic therapy is achieved by a single wavelength of near‐infrared laser. RNA sequencing is performed to identify differentially expressed genes, which show that the expressions of proliferation and migration‐associated genes are inhibited, while the apoptosis and immune response gene expressions are upregulated after the synergistic treatments. This multifunctional nanoplatform that responds to the TME to realize the on‐demand payload release and enhance PDT induced by TME modulation holds great promise for clinical applications in tumor therapy.
- 10 September 2023
- Published by Wiley in Advanced Healthcare Materials
- Vol. 12 (28) , e2301413
Mn2+/Ir3+‐Doped and CaCO3‐Covered Prussian Blue Nanoparticles with Indocyanine Green Encapsulation for Tumor Microenvironment Modulation and Image‐Guided Synergistic Cancer Therapy
The development of smart theranostic nanoplatforms has gained great interest in effective cancer treatment against the complex tumor microenvironment (TME), including weak acidity, hypoxia, and glutathione (GSH) overexpression. Herein, a TME‐responsive nanoplatform named PMICApt/ICG, based on PB:Mn&Ir@CaCO3Aptamer/ICG, is designed for the competent synergistic photothermal therapy and photodynamic therapy (PDT) under the guidance of photothermal and magnetic resonance imaging. The nanoplatform's aptamer modification targeting the transferrin receptor and the epithelial cell adhesion molecule on breast cancer cells, and the acid degradable CaCO3 shell allow for effective tumor accumulation and TME‐responsive payload release in situ. The nanoplatform also exhibits excellent PDT properties due to its ability to generate O2 and consume antioxidant GSH in tumors. Additionally, the synergistic therapy is achieved by a single wavelength of near‐infrared laser. RNA sequencing is performed to identify differentially expressed genes, which show that the expressions of proliferation and migration‐associated genes are inhibited, while the apoptosis and immune response gene expressions are upregulated after the synergistic treatments. This multifunctional nanoplatform that responds to the TME to realize the on‐demand payload release and enhance PDT induced by TME modulation holds great promise for clinical applications in tumor therapy.
- 7 September 2023
- Published by Springer Nature in Science China Materials
- Vol. 66 (10) , 4121-4130
Facile synthesis of Fe3O4@polyethylenimine with peroxidase-like activity for highly sensitive detection of interferon α-2b
- 7 September 2023
- Published by Springer Nature in Science China Materials
- Vol. 66 (10) , 4121-4130
Facile synthesis of Fe3O4@polyethylenimine with peroxidase-like activity for highly sensitive detection of interferon α-2b
- 17 June 2023
- Published by Elsevier in Chinese Chemical Letters
- Vol. 35 (2) , 108683
Elaborately engineering of lipid nanoparticle for targeting delivery of siRNA and suppressing acute liver injury
- 17 June 2023
- Published by Elsevier in Chinese Chemical Letters
- Vol. 35 (2) , 108683
Elaborately engineering of lipid nanoparticle for targeting delivery of siRNA and suppressing acute liver injury
- 19 May 2023
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 15 (21) , 25427-25436
Paintable Bioactive Extracellular Vesicle Ink for Wound Healing
The treatment of cutaneous wounds involving complex biological processes has become a significant public health concern worldwide. Here, we developed an efficient extracellular vesicle (EV) ink to regulate the inflammatory microenvironment and promote vascular regeneration for wound healing. The technology, termed portable bioactive ink for tissue healing (PAINT), leverages bioactive M2 macrophage-derived EVs (EVM2) and a sodium alginate precursor, forming a biocompatible EV-Gel within 3 min after mixing, enabling it to be smeared on wounds in situ to meet diverse morphologies. The bioactive EVM2 reprogram macrophage polarization and promote the proliferation and migration of endothelial cells, thereby effectively regulating inflammation and enhancing angiogenesis in wounds. Through integration with a 3D printing pen, the platform enables EV-Gel to be applied to wound sites having arbitrary shapes and sizes with geometric matches for tissue repairment. When evaluated using a mouse wound model, PAINT technology accelerates cutaneous wound healing by promoting the angiogenesis of endothelial cells and the polarization of macrophages to M2 phenotype in vivo, demonstrating the high potential of bioactive EV ink as a portable biomedical platform for healthcare.
- 19 May 2023
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 15 (21) , 25427-25436
Paintable Bioactive Extracellular Vesicle Ink for Wound Healing
The treatment of cutaneous wounds involving complex biological processes has become a significant public health concern worldwide. Here, we developed an efficient extracellular vesicle (EV) ink to regulate the inflammatory microenvironment and promote vascular regeneration for wound healing. The technology, termed portable bioactive ink for tissue healing (PAINT), leverages bioactive M2 macrophage-derived EVs (EVM2) and a sodium alginate precursor, forming a biocompatible EV-Gel within 3 min after mixing, enabling it to be smeared on wounds in situ to meet diverse morphologies. The bioactive EVM2 reprogram macrophage polarization and promote the proliferation and migration of endothelial cells, thereby effectively regulating inflammation and enhancing angiogenesis in wounds. Through integration with a 3D printing pen, the platform enables EV-Gel to be applied to wound sites having arbitrary shapes and sizes with geometric matches for tissue repairment. When evaluated using a mouse wound model, PAINT technology accelerates cutaneous wound healing by promoting the angiogenesis of endothelial cells and the polarization of macrophages to M2 phenotype in vivo, demonstrating the high potential of bioactive EV ink as a portable biomedical platform for healthcare.